GlassScriptPhysician profile
Kazi Ullah
NPI 1841750692
$1,357.76
in general payments reported to CMS, 2019-2025
9 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.01 | 2025 | |
| Gilead Sciences, INC. | $198.83 | 2025 | Livdelzi |
| Olympus America INC. | $131.40 | 2025 | Single Use Biliary Balloon Dilator, Endoclot Sis |
| Mallinckrodt Hospital Products INC. | $66.97 | 2025 | Terlivaz |
| Takeda Pharmaceuticals U.S.A., INC. | $38.20 | 2025 | Eohilia, Gattex |
| Ardelyx, INC. | $31.25 | 2025 | Ibsrela |
| Madrigal Pharmaceuticals | $30.06 | 2025 | Rezdiffra |
| Genzyme Corporation | $24.22 | 2025 | |
| Boston Scientific Corporation | $15.82 | 2025 | Resolution 360 Ultra Clip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kazi Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.